Low density lipoprotein (LDL) incubated with cultured endothelial cells from rabbit aorta or human umbilical vein is altered in several ways (EC-modified): (i) It is degraded by macrophages much faster than LDL similarly incubated in the absence of cells or incubated with fibroblasts.
The lipid-laden foam cells in atherosclerotic lesions are derived largely or in part from monocyte/macrophages (1, 2) . These cells have only low levels of the classical low density lipoprotein (LDL) receptor and take up native LDL in vitro at relatively low rates, insufficient to cause lipid accumulation to the extent found in vivo (3) . It has been suggested that this paradox may be explained if the LDL particle is in some way altered in vivo to a form taken up more readily than native LDL. Certain chemically modified forms of LDL, including acetylated LDL, are indeed taken up much more rapidly than native LDL by macrophages, and this uptake involves a different receptor, designated the acetyl-LDL receptor (3) (4) (5) . Incubation of LDL with cultured endothelial cells generates a modified form (or forms) of LDL (endothelial cell-modified LDL; EC-modified LDL) that is taken up 3-to 10-fold more rapidly by macrophages and at least in part by way of the acetyl-LDL receptor (6) (7) (8) . The modification in biological properties is accompanied by a marked increase in electrophoretic mobility and hydrated density but the mechanisms involved are still poorly understood.
LDL is highly sensitive to metal-catalyzed oxidation (9-11) and oxidized LDL has been shown to be toxic to some cultured cells (12, 13) . Endothelial cells in culture have been shown to be capable of oxidizing LDL (14) . Since the modification of LDL by endothelial cells involves long incubation under aerobic conditions, we examined the possible role of oxidative changes in the process. In the present paper, we report that generation of EC-modified LDL is associated with lipid peroxidation and with extensive hydrolysis of LDL phosphatidylcholine (PtdCho) to lysophosphatidylcholine (lyso-PtdCho).
MATERIALS AND METHODS Materials. Carrier-free Na125I and [1-14C] linoleic acid were purchased from Amersham. Ham's F-10 medium was obtained from Irvine Scientific; a minimal essential medium (a-ME medium) and Dulbecco's modified Eagle's (DME) medium were from GIBCO; and media 199, RPMI 1640, and NCTC 109 were from M. A. Bioproducts (Walkersville, MD). Fetal bovine serum was from HyClone (Logan, UT). Female Swiss Webster mice were supplied by Simonsen Laboratories (Gilroy, CA). Butylated hydroxytoluene was obtained from J. T. Baker Chemical (Phillipsburg, NJ); D-atocopherol (vitamin E) was from United States Biochemical (Cleveland, OH); and phospholipase A2 (from Ophiophagus hannah venom) was from Miami Serpentarium (Miami, FL).
Lipoproteins. LDL (p = 1.019-1.063) was isolated by ultracentrifugation from pooled normal human plasma collected in EDTA (1 mg/ml) and radioiodinated with Na'25I using a modification of the ICI method of McFarlane (15) ; then, the product was dialyzed against phosphate-buffered saline/0.01% EDTA. Protein was determined by the Lowry method (16), using bovine serum albumin as a standard.
Cells. The rabbit aortic endothelial cells used were from a line established and characterized by Buonassisi and coworkers (17) . These cells were grown in Ham's F-10 medium/15% fetal bovine serum containing epidermal growth factor at 10 ng/mnl in 60-mm plastic culture dishes and were used for experiments at confluence. Resident peritoneal macrophages were isolated from female Swiss Webster mice by lavage with Dulbecco's phosphate-buffered saline. Peritoneal cells were suspended in a-ME medium, with gentamicin sulfate (50 ,ug/ml), amphotericin B (2.5 1fg/ml), and 10% fetal bovine serum and plated at 2 x 106 cells per dish. Nonadherent cells were removed 1 hr after plating, and the adherent macrophages were used in experiments the following day.
Modification of LDL. Endothelial cells were washed three times with serum-free medium and then incubated with 2 ml of serum-free medium containing 100 Ag of LDL protein/ml. At the end of the incubation at 370C (usually 24 In previous studies from this laboratory on the production of EC-modified LDL, incubations were routinely carried out in Ham's F-10 medium (6-8). We now find that the modification does not take place if DME medium is used in place of F-10 even though incubation conditions are in all other respects identical. There is no change in electrophoretic mobility or hydrated density nor in the rate of subsequent degradation when the LDL is transferred to cultured macrophages (Fig. 2) . Modification also failed to occur in medium 199, a-ME medium, RPMI 1640, or NCTC 109. This could be due to the presence of inhibitory substances in these media or to the lack of factors such as transition metals that could catalyze peroxidation. Evidence that transition metal ions might be crucial was obtained by demonstrating a complete inhibition of the modification in F-10 medium when 50 AM EDTA was added (Fig. 2) . This low concentration of EDTA could complex only a small proportion of the Ca2' and Mg2' but, because of the extremely high association constant of EDTA for Fe2+, Cu2+, and Zn2+ and because of their much lower concentrations in the medium, these ions would be almost quantitatively complexed. Further evidence for the importance of metal ions was the finding that supplementation of DME medium with Cu2' allowed modification to occur (Fig.   2) . However, the relative importance of different metal ions in EC-modification remains to be established. As shown in Fig. 3 , the modification of LDL by EC appeared to be accompanied by extensive hydrolysis of the PtdCho in LDL to lyso-PtdCho. The appearance of phospholipid comigrating with lyso-PtdCho could not have been due to oxidized PtdCho as, with the solvent system used, oxidized PtdCho would be expected to move only slightly slower than PtdCho and much faster than lyso-PtdCho (23). Furthermore, the isolated material could be acylated to the parent compound PtdCho, thus establishing its chemical nature as lyso-PtdCho. The phospholipid/protein ratio of EC-modified LDL reisolated by ultracentrifugation was unchanged from that of native LDL, in agreement with previous results from this laboratory (7) . Thus, the lyso-PtdCho generated remains associated with LDL under the conditions of the incubation. In some experiments, PtdCho labeled with [1-14C]linoleic acid in the 2-position was added along with unlabeled LDL at the beginning of incubation with endothelial cells and the medium was analyzed at various time intervals (Fig. 4) . There was a progressive decrease in PtdCho radioactivity that closely paralleled the decrease in PtdCho mass, indicating that the fate of the labeled PtdCho reflected that of the total PtdCho present in LDL. As much as 40% of the PtdCho in the LDL added had been hydrolyzed by the end of a 24-hr incubation. However, almost no radioactivity was recovered in the lyso-PtdCho, indicating that the labeled 2-position fatty acid and not the unlabeled 1-position fatty acid was cleaved during modification. This specificity suggests that a phospholipase A2 activity may be involved. Because the fatty acid was labeled at the carbonyl carbon, loss of radioactivity by nonenzymatic scission of the acyl chain at a peroxidized double bond can be excluded. There is no precedent for loss of the entire fatty acyl chain by nonenzymatic oxidative degradation. Most of the released radioactivity remained in the aqueous phase after acidification and extraction with hexane, a procedure that would remove nonoxidized fatty acids. The findings are thus compatible with the interpretation that at least some of the thiobarbituric acidreactive substances in the medium represent oxidized or per- oxidized fatty acids cleaved from PtdCho during the course of the incubation. The possibility that a lecithin:cholesterol acyltransferase might be responsible for the hydrolysis of PtdCho was considered since in the absence of an acceptor (cholesterol) this enzyme can act as a hydrolase (24) . However, the radioactivity lost from PtdCho was not recovered in the cholesterol ester fraction on TLC. Furthermore, heating LDL at 60'C for 60 min, which is sufficient to inactivate this enzyme, did not prevent EC-modification.
A surprising finding was that the hydrolysis of PtdCho was also inhibited by antioxidants that prevent EC-modification (Table 1) . It has been shown that oxidized phospholipids are more susceptible to hydrolysis by phospholipases (25) and this may be the link between the oxidation and the PtdCho hydrolysis noted here. However, this conclusion remains tentative because the antioxidants may have direct effects on the phospholipase activities involved in EC-modification.
In the present studies, incubation periods were limited to 24 hr or less and LDL was added at 100 pug of protein/ml.
LDL incubated under identical conditions in the absence of cells shows little or no modification (Fig. 1, control LDL) , as previously reported (6, 8 significance of differences was assessed with the two-tailed t test (*, P < 0.001; t, P < 0.02). 125I-labeled LDL was incubated for 48 hr in F-10 medium (containing glutamine and gentamicin) in 60-mm dishes containing endothelial cells or in cell-free dishes that had previously been incubated with serum-containing medium. It was then subjected to low-speed centrifugation and the radioactivity in a sample of the supernatant was measured. The concentration of the 125I-labeled LDL was then calculated from its specific activity and aliquots were added to 22-mm dishes of macrophages or cell-free dishes at a concentration of 10 /ig of LDL-protein/ml in F-10 medium (containing glutamine and gentamicin). Degradation of the '25I-labeled LDL was determined after 5 hr. Values shown are means ± SD for three dishes of macrophages. The electrophoretic mobility of the control and EC-modified LDL was determined in agarose gels (pH 8.6, 300 V, 30 mA, 2 hr). Whether or not the 60-mm dishes were first incubated with serum-containing medium had no effect on degradation of the 1251_ (26, 27) , which could account for generation of some of the thiobarbituric acid-reactive material measured.
Whatever the precise mechanisms involved may be, these findings implicate free radicals and peroxidation (in the medium, in the cells, or both) as a key element in generation of EC-modified LDL. Whether a similar process occurs in vivo at a rate significant enough to contribute to atherosclerosis remains to be determined. Preliminary data from our laboratory and from others (28, 29) show that under appropriate conditions cultured smooth muscle cells, stimulated polymorphonuclear cells, and monocyte/macrophages themselves can lead to oxidation of LDL. Such oxidation of LDL might occur in the artery wall, where the levels of antioxidants may be lower than in whole blood. In fact, LDL isolated from the arterial wall (30) and from inflammatory fluids (31) shares some properties of EC-modified LDL but these modified lipoproteins have not yet been completely characterized. If the processes described here do play a role in vivo, it would in theory be possible to intervene and alter the atherogenic process by using antioxidants or phospholipase inhibitors or both. (1984) 
